Skip to content

How Menopause Affects Lipid Metabolism in the Visceral Fat Depots

How Menopause Affects Lipid Metabolism in the Visceral Fat Depots

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02524457
Enrollment
60
Registered
2015-08-14
Start date
2015-09-30
Completion date
2020-09-30
Last updated
2015-08-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insulin Sensitivity and Lipid Metabolism

Brief summary

The purpose of the study is to describe the molecular mechanisms related to an increased visceral fat mass and changed T-cell homeostasis. the project is expected to add new knowledge to the field of metabolic diseases after menopause and increase the focus of how lipid affects the development of metabolic disease in relation to the menopausal transition.

Detailed description

The study is a cross sectional study including 60 women between 45 and 55 years of age. Investigators aim to include 20 premenopausal women, 20 postmenopausal women and 20 postmenopausal women taking hormone treatment (HT). All the women are going through gynecological surgery for benign reasons. During the operation investigators will take a visceral fat biopsy from the omentum. maximally 1 month before- or after the operation the subject will meet at the lab for further testing, including: * Health examination * Blood samples * OGTT * DXA scan * VO2 max testing * MRI of the abdomen * hyperinsulinemic euglycemic clamp

Interventions

OTHERThis is an observational study. There are no interventions

Sponsors

Rigshospitalet, Denmark
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Age
45 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

* women * 45-55 years old * for HT treated women (HT more than 1 year)

Exclusion criteria

* Infections during the last month * chronic disease * claustrophobia * smoking * Alcoholic intake \> 14 servings * hysterectomy before menopause * oophorectomized * early menopause (before 40 yrs) * BMI \> 30

Design outcomes

Primary

MeasureTime frameDescription
Insulin sensitivity4 weeksmeasured through a hyperinsulinemic euglycemic clamp (Outcome: glucose infusion rate)

Contacts

Primary ContactJulie Abildgaard, MD
julie.abildgaard.01@regionh.dk+4535457190

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026